Parallellhandel och hur den påverkar läkemedelspriser - Marknadsdynamiken mellan parallellimportör och originalfabrikant
In a market with homogeneous products and no barriers to trade, arbitrage, in the form of parallel imports of pharmaceuticals, is expected to lead to a price convergence in the market as a whole, preferably downwards, as an effect of competitive behavior between the parallel trader and the pharmaceutical producer. Such an effect on prices have however only sparsely been shown in previous research,
